Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
about
'Big data' in mental health research: current status and emerging possibilitiesGenetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)The serotonin system in autism spectrum disorder: From biomarker to animal modelsPrenatal SSRI use and offspring with autism spectrum disorder or developmental delay.In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.Diagnosing and Treating Depression During Pregnancy.Perinatal Generalized Anxiety Disorder: Assessment and Treatment.Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative dataGestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.Are Attributes of Pregnancy and the Delivery Room Experience Related to Development of Autism? A Review of the Perinatal and Labor Risk Factors and Autism.Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A ReviewAbsence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.Use of databases for clinical research.Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis.Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition.The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.Antidepressants during pregnancy and autism in offspring: population based cohort study.Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder.Autism risk following antidepressant medication during pregnancy.Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors.Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy.Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study.Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis.
P2860
Q26741297-C4A50CF6-2C8A-4042-A670-75B8381448AAQ26741618-D18CF10A-5A0C-439F-B6D8-9D5DC9A19192Q28391614-F22F0730-2189-4D12-9022-2CCAE1F72C66Q33551798-D49842CC-205B-4CE7-9015-DBDC15BF06CAQ34040844-BCC96CD6-1E95-4CA9-A930-E0AB8A9A2654Q34047430-DB9022C4-40D8-453E-A678-CEE6AB63BE10Q35593830-46C925AC-3E3C-463E-84D5-E52D71AF513AQ35963421-5BB6859E-35F0-4058-9851-5A9DE2DDB7E2Q36028297-635EB757-C7D5-4A17-92E6-6AD61ECBDF53Q36108616-8F9B8B2F-523F-49D9-816B-F255ACEB05EFQ36207250-CCD064DA-B2AB-4BE5-89CE-8B9A83BB1B3AQ36853542-4745C53A-924A-492A-93CC-0CF53AEB04BCQ36979990-4100D5AA-4884-425B-8739-CE079DF1A35AQ37032700-CB99BD96-783F-44AC-B083-48099A5D6673Q37347807-FC3059E4-A368-4AB1-965E-A35286E40A1CQ38184532-2B2675C0-034C-4929-BD73-9FA2DB8C253CQ38220994-B6C3FE58-E0E7-4668-B8F7-0784B8BF78B4Q38305749-5C93848D-D1B4-4177-A795-F02090F6D4F7Q38532482-5CCA3D79-29BF-4673-A9D7-296DFBA00957Q38653267-1D76950F-9DE8-4E27-A8CA-37BEB1A21435Q38653394-489A1BA0-5A2B-4D07-ADFC-322BF714DFDCQ38702052-78451187-675E-44FF-BCBF-91BD82659770Q38722632-FE79CE4C-D0CC-4EC2-8E8F-0201B5332023Q38784504-439613F7-614A-488C-9A3F-19CF74ABAD66Q38823790-88CABA6B-2F51-4975-A441-29D151CB77E9Q38909371-807D2253-95F1-4A6C-9D91-5D842A658414Q40116223-99A308BC-84F2-4873-8F97-798373D6FDB6Q40125660-F2E69062-DC0F-4522-89AE-48E4AB4D66E3Q40583260-2848107F-9791-4A77-8546-81846ABEE8AFQ41285360-78F16BCB-AAF8-4193-A402-728277D7E22FQ42444090-1CE2E6B5-B6FC-4628-8D97-78B827B73923Q47561017-B074723A-D547-49C2-AC1D-619F0413CB50Q47655108-8C6395BD-3E5E-4239-8D49-7170E44D972DQ47717631-5E20C275-DBC0-4EC2-A90A-CAB34FEF648CQ47733055-9AAA43F7-3785-4434-9258-BCACA723103FQ47743073-9FBD07F7-5422-44D8-98D5-E60AE8FD6087Q47801409-0BF0D067-DE22-456C-8D19-6E95775FD593Q50307230-78B975D1-0A66-4D23-8F73-BF53A4A8D7A1Q52582925-4C11F1DD-8209-4B5C-A8DF-CB7E4BC864CAQ53277650-A8B43243-F63D-4DED-A941-C8625017B668
P2860
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@ast
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@en
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@nl
type
label
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@ast
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@en
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@nl
prefLabel
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@ast
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@en
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@nl
P50
P356
P1476
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
@en
P304
P356
10.1056/NEJMOA1301449
P407
P577
2013-12-01T00:00:00Z